FDA to probe pulse oximeters amid questions of accuracy, effect of COVID-19 on people of color

Physicians are less likely to detect serious cases of COVID-19 among people of color because of false pulse oximeter readings, provoking the FDA to discuss the issue with an advisory panel scheduled for later this year, according to Politico. 

Read the full post on Becker's Hospital Review - Healthcare News